🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Low

Tamibarotene

Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.

Tags: acute myeloid leukemia, biopharmaceutical, cancer treatment, gene control, myelodysplastic syndrome, pharmaceutical development

Symbol: SYRS

Recent Price: $0.25

Industry: Biotechnology

CEO: Mr. Conley Chee

Sector: Healthcare

Employees: 68

Address: 35 CambridgePark Drive, Cambridge, MA 02140

Phone: 617 744 1340

Leadership

  • Conley Chee, President and Chief Executive Officer
  • Jason Haas, Chief Financial Officer
  • Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
  • Lisa Roberts, VP Human Resources
  • David A. Roth, M.D., Chief Medical Officer
  • Kristin Stephens, Chief Development Officer

Last updated: 2024-12-31